The devil is in the data: differences in drug persistence between SNIIRAM, the French national health insurance database, and psoriasis biologics intervention registers

Br J Dermatol. 2019 Jan;180(1):8-10. doi: 10.1111/bjd.17275.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Biological Products*
  • Databases, Factual
  • Humans
  • Language
  • National Health Programs
  • Psoriasis*

Substances

  • Biological Products